Key result
Multimodality imaging guides personalized medical, surgical, and catheter-based therapies for mitral regurgitation in HCM.
Why the study?
Significant mitral regurgitation is frequent in hypertrophic cardiomyopathy and is associated with poor long-term outcomes, highlighting the need for adequate MR assessment and mitral valve evaluation.
Multimodality imaging may guide mechanism-specific MR therapy in HCM; extends consensus but leaves standardized protocols open for validation.
Significant mitral regurgitation (MR) is frequent in patients with hypertrophic cardiomyopathy (HCM) either obstructive or non-obstructive. Many studies described that significant MR is associated with poor long-term outcome of HCM patients, which indicate the importance of an adequate MR assessment including detailed evaluation of the mitral valve (MV) anatomy. Mitral malformations have been identified in HCM at all levels.
No takes yet. Share an insight, caveat, or question.
Anwar Ashraf M (2022) conducted a review in Hypertrophic Cardiomyopathy with Mitral Regurgitation. Multimodality imaging and targeted management was evaluated. Mitral regurgitation in hypertrophic cardiomyopathy requires detailed multimodality imaging to understand its mechanism and guide individualized medical, surgical, or catheter-based therapies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: